The PAX6-ZEB2 axis promotes metastasis and cisplatin resistance in non-small cell lung cancer through PI3K/AKT signaling
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The PAX6-ZEB2 axis promotes metastasis and cisplatin resistance in non-small cell lung cancer through PI3K/AKT signaling
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 10, Issue 5, Pages -
Publisher
Springer Nature
Online
2019-04-25
DOI
10.1038/s41419-019-1591-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Transcription factor PAX6 as a novel prognostic factor and putative tumour suppressor in non-small cell lung cancer
- (2018) Yury Kiselev et al. Scientific Reports
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- HPIP expression predicts chemoresistance and poor clinical outcomes in patients with epithelial ovarian cancer
- (2017) Yao Wang et al. HUMAN PATHOLOGY
- The Cdc42/Rac1 regulator CdGAP is a novel E-cadherin transcriptional co-repressor with Zeb2 in breast cancer
- (2017) Y He et al. ONCOGENE
- NatD promotes lung cancer progression by preventing histone H4 serine phosphorylation to activate Slug expression
- (2017) Junyi Ju et al. Nature Communications
- Simultaneous overactivation of Wnt/β-catenin and TGFβ signalling by miR-128-3p confers chemoresistance-associated metastasis in NSCLC
- (2017) Junchao Cai et al. Nature Communications
- FKBP3 Promotes Proliferation of Non-Small Cell Lung Cancer Cells through Regulating Sp1/HDAC2/p27
- (2017) Wenzhuo Zhu et al. Theranostics
- Prolonged pemetrexed pretreatment augments persistence of cisplatin-induced DNA damage and eliminates resistant lung cancer stem-like cells associated with EMT
- (2016) Colin Charles Tièche et al. BMC CANCER
- The circadian clock gene Bmal1 acts as a potential anti-oncogene in pancreatic cancer by activating the p53 tumor suppressor pathway
- (2016) Weiliang Jiang et al. CANCER LETTERS
- The ERK–ZEB1 pathway mediates epithelial–mesenchymal transition in pemetrexed resistant lung cancer cells with suppression by vinca alkaloids
- (2016) L-Y Chiu et al. ONCOGENE
- Hematopoietic pre-B cell leukemia transcription factor interacting protein is overexpressed in gastric cancer and promotes gastric cancer cell proliferation, migration, and invasion
- (2015) Yingying Feng et al. CANCER SCIENCE
- MicroRNA-7 inhibits the malignant phenotypes of non-small cell lung cancer in vitro by targeting Pax6
- (2015) JIASHUN LUO et al. Molecular Medicine Reports
- Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
- (2015) Xiaofeng Zheng et al. NATURE
- Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
- (2015) Kari R. Fischer et al. NATURE
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Ubiquitin ligase Cbl-b represses IGF-I-induced epithelial mesenchymal transition via ZEB2 and microRNA-200c regulation in gastric cancer cells
- (2014) Heming Li et al. Molecular Cancer
- Downregulation of PAX6 by shRNA Inhibits Proliferation and Cell Cycle Progression of Human Non-Small Cell Lung Cancer Cell Lines
- (2014) Xiaoting Zhao et al. PLoS One
- Signaling mechanisms of the epithelial-mesenchymal transition
- (2014) D. M. Gonzalez et al. Science Signaling
- Insulin-like growth factor-I induces epithelial to mesenchymal transition via GSK-3β and ZEB2 in the BGC-823 gastric cancer cell line
- (2014) HEMING LI et al. Oncology Letters
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- TGF-β signaling and epithelial–mesenchymal transition in cancer progression
- (2012) Yoko Katsuno et al. CURRENT OPINION IN ONCOLOGY
- Tumor angiogenesis: molecular pathways and therapeutic targets
- (2011) Sara M Weis et al. NATURE MEDICINE
- A Perspective on Cancer Cell Metastasis
- (2011) C. L. Chaffer et al. SCIENCE
- Pax6 Is a Human Neuroectoderm Cell Fate Determinant
- (2010) Xiaoqing Zhang et al. Cell Stem Cell
- Isoform- and dose-sensitive feedback interactions between paired box 6 gene and δ-catenin in cell differentiation and death
- (2010) Jiao Zhang et al. EXPERIMENTAL CELL RESEARCH
- Non-Small Cell Lung Cancer Cells Expressing CD44 Are Enriched for Stem Cell-Like Properties
- (2010) Elaine Lai-Han Leung et al. PLoS One
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- PAX6 Is Expressed in Pancreatic Cancer and Actively Participates in Cancer Progression through Activation of the MET Tyrosine Kinase Receptor Gene
- (2009) Joseph B. Mascarenhas et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis
- (2008) Jing Yang et al. DEVELOPMENTAL CELL
- Concise Review: Pax6 Transcription Factor Contributes to both Embryonic and Adult Neurogenesis as a Multifunctional Regulator
- (2008) Noriko Osumi et al. STEM CELLS
- PAX6 is expressed in pancreatic adenocarcinoma and is downregulated during induction of terminal differentiation
- (2007) Deborah Lang et al. MOLECULAR CARCINOGENESIS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started